Board MeetingOutcome of Board Meeting
Quest Laboratories' Board approved audited standalone FY26 results: PAT ₹14.89 Cr, EPS ₹9.16. No dividend declared.
Quest Laboratories LimitedQUESTLAB · Filed with the exchange
The company also acquired land for ₹3.21 Cr for manufacturing expansion & approved new internal, secretarial, and cost auditors for FY27.
No comments yet. Be the first.